These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 16518761)

  • 1. Recombinant human erythropoietin prevents the death of mice during cerebral malaria.
    Kaiser K; Texier A; Ferrandiz J; Buguet A; Meiller A; Latour C; Peyron F; Cespuglio R; Picot S
    J Infect Dis; 2006 Apr; 193(7):987-95. PubMed ID: 16518761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human erythropoietin increases survival and reduces neuronal apoptosis in a murine model of cerebral malaria.
    Wiese L; Hempel C; Penkowa M; Kirkby N; Kurtzhals JA
    Malar J; 2008 Jan; 7():3. PubMed ID: 18179698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On recombinant human erythropoietin preventing the death of mice during cerebral malaria.
    Lackner P; Helbok R; Schmutzhard E
    J Infect Dis; 2007 May; 195(9):1391; author reply 1391-2. PubMed ID: 17397015
    [No Abstract]   [Full Text] [Related]  

  • 4. Estradiol, but not dehydroepiandrosterone, decreases parasitemia and increases the incidence of cerebral malaria and the mortality in plasmodium berghei ANKA-infected CBA mice.
    Libonati RM; Cunha MG; Souza JM; Santos MV; Oliveira SG; Daniel-Ribeiro CT; Carvalho LJ; do Nascimento JL
    Neuroimmunomodulation; 2006; 13(1):28-35. PubMed ID: 16699290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artesunate-erythropoietin combination for murine cerebral malaria treatment.
    Bienvenu AL; Ferrandiz J; Kaiser K; Latour C; Picot S
    Acta Trop; 2008 May; 106(2):104-8. PubMed ID: 18359468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmodium berghei ANKA: erythropoietin activates neural stem cells in an experimental cerebral malaria model.
    Core A; Hempel C; Kurtzhals JA; Penkowa M
    Exp Parasitol; 2011 Feb; 127(2):500-5. PubMed ID: 21044627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of IFN-gamma receptor-medicated signaling in pathology and anti-malarial immunity induced by Plasmodium berghei infection.
    Amani V; Vigário AM; Belnoue E; Marussig M; Fonseca L; Mazier D; Rénia L
    Eur J Immunol; 2000 Jun; 30(6):1646-55. PubMed ID: 10898501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of indoleamine 2,3-dioxygenase in murine malaria infection is predominantly localised to the vascular endothelium.
    Hansen AM; Ball HJ; Mitchell AJ; Miu J; Takikawa O; Hunt NH
    Int J Parasitol; 2004 Nov; 34(12):1309-19. PubMed ID: 15542091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with liposome-bound recombinant human tumor necrosis factor-alpha suppresses parasitemia and protects against Plasmodium berghei k173-induced experimental cerebral malaria in mice.
    Postma NS; Crommelin DJ; Eling WM; Zuidema J
    J Pharmacol Exp Ther; 1999 Jan; 288(1):114-20. PubMed ID: 9862761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmodium berghei: cerebral malaria in CBA mice is not clearly related to plasma TNF levels or intensity of histopathological changes.
    Carvalho LJ; Lenzi HL; Pelajo-Machado M; Oliveira DN; Daniel-Ribeiro CT; Ferreira-da-Cruz MF
    Exp Parasitol; 2000 May; 95(1):1-7. PubMed ID: 10864512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malaria mimicry with tumor necrosis factor. Contrasts between species of murine malaria and Plasmodium falciparum.
    Clark IA; MacMicking JD; Gray KM; Rockett KA; Cowden WB
    Am J Pathol; 1992 Feb; 140(2):325-36. PubMed ID: 1739126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral malaria: protection by erythropoietin.
    Bienvenu AL; Picot S
    Methods Mol Biol; 2013; 982():315-24. PubMed ID: 23456877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Erythropoietin--a new therapy in cerebral ischemia?].
    Kalialis LV; Olsen NV
    Ugeskr Laeger; 2003 Jun; 165(24):2477-81. PubMed ID: 12872467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioimmunotherapy of rodent malaria: co-treatment with recombinant mouse granulocyte-macrophage colony-stimulating factor and an enkephalin fragment peptide Tyr-Gly-Gly.
    Kaur A; Kinhikar AG; Singh PP
    Acta Trop; 2004 Jun; 91(1):27-41. PubMed ID: 15158686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin 2nd cerebral protection after acute injuries: a double-edged sword?
    Velly L; Pellegrini L; Guillet B; Bruder N; Pisano P
    Pharmacol Ther; 2010 Dec; 128(3):445-59. PubMed ID: 20732352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malarial anaemia: mechanisms and implications of insufficient erythropoiesis during blood-stage malaria.
    Chang KH; Stevenson MM
    Int J Parasitol; 2004 Dec; 34(13-14):1501-16. PubMed ID: 15582527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose erythropoietin alters platelet reactivity and bleeding time in rodents in contrast to the neuroprotective variant carbamyl-erythropoietin (CEPO).
    Kirkeby A; Torup L; Bochsen L; Kjalke M; Abel K; Theilgaard-Monch K; Johansson PI; Bjørn SE; Gerwien J; Leist M
    Thromb Haemost; 2008 Apr; 99(4):720-8. PubMed ID: 18392330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin protects cardiomyocytes from apoptosis via up-regulation of endothelial nitric oxide synthase.
    Burger D; Lei M; Geoghegan-Morphet N; Lu X; Xenocostas A; Feng Q
    Cardiovasc Res; 2006 Oct; 72(1):51-9. PubMed ID: 16904088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect on cerebral inflammatory agents that accompany traumatic brain injury in a rat model: a potential neuroprotective mechanism of recombinant human erythropoietin (rhEPO).
    Chen G; Shi JX; Hang CH; Xie W; Liu J; Liu X
    Neurosci Lett; 2007 Oct; 425(3):177-82. PubMed ID: 17825990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effect of erythropoietin, and role of metallothionein-1 and -2, in permanent focal cerebral ischemia.
    Wakida K; Shimazawa M; Hozumi I; Satoh M; Nagase H; Inuzuka T; Hara H
    Neuroscience; 2007 Aug; 148(1):105-14. PubMed ID: 17624681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.